Nuvo Pharmaceuticals Growth, Revenue, Number of Employees and Funding

Overview

Location:
Toronto, ON Canada
Total Funding:N/A
Industry:Pharma
Founded:1983
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Nuvo Pharmaceuticals's estimated revenue is currently $8.4M per year.
  • Nuvo Pharmaceuticals received $6.0M in venture funding in August 2017.
  • Nuvo Pharmaceuticals's estimated revenue per employee is $156333

Employee Data

  • Nuvo Pharmaceuticals has 54 Employees.
  • Nuvo Pharmaceuticals grew their employee count by 20% last year.
  • Nuvo Pharmaceuticals currently has 1 job openings.

What Is Nuvo Pharmaceuticals?

Nuvo (TSX:NRI) is a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo has three commercial products that are available in a number of countries; Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine patch. Pennsaid 2% is sold in the U.S. by Horizon Pharma plc (NASDAQ:HZNP) and is available for partnering in certain other territories around the world. Nuvo manufactures Pennsaid for the global market and Pennsaid 2% for the U.S. market at its FDA licensed GMP facility in Varennes, Québec.

keywords:N/A

54

Number of Employees

$8.4M

Revenue (est)

1

Current Jobs

20%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Turnkey Modular...
$5.8M3530%
HLS Therapeutic...
$7M4114%
PharmEng Techno...
$27.1M15713%
Allphase Clinic...
$7M3712%
Janssen
$1342.5M71657%
Fresenius Kabi ...
$19.8M10821%
Everest Clinica...
$26.9M16418%
Robarts Clinica...
$41.4M24014%
Novapharm Limit...
N/A932%
Dalton Pharma S...
$23.1M1254%

Nuvo Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2017-08-25$6.0MUndisclosedRoyal Bank of Canada (RBC)Article

Nuvo Pharmaceuticals Executive Hires

DateNameTitleReference
2017-11-23Jesse LedgerPresident/CEOArticle
2017-11-23John LondonChairmanArticle